Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sahul, Zakir
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)	Recruiting	3	12500	Europe, Canada, Japan, US, RoW	Lepodisiran Sodium, LY3819469, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)	03/29	03/29
Marchelletta, Nora
NCT02438306: CardiAMP™ Cell Therapy for Heart Failure Trial	Active, not recruiting	3	125	Canada, US	Autologous cell therapy, Sham	BioCardia, Inc.	Heart Failure, Systolic	12/24	12/26
Assert-IQ, NCT06172699: Implantable Cardiac Monitor (ICM) Post Market Study	Recruiting	N/A	150	US	Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device	Abbott Medical Devices	Atrial Fibrillation Paroxysmal, Atrial Fibrillation, Persistent, Cardiac Arrhythmia, Ablation	10/24	09/25
NCT04190186: Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation	Completed	N/A	55	US	Insertable Cardiac Monitor, BioMonitor3® or future generation of Biotronik ICM	University of Rochester, Biotronik, Inc.	Persistent Atrial Fibrillation	02/24	02/24